BioLASCO Taiwan Co., Ltd. (TPEX:6662)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.75
+0.10 (0.34%)
At close: Feb 11, 2026

BioLASCO Taiwan Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
277.12292.5264.72235.91227.58298.88
Revenue Growth (YoY)
-4.65%10.49%12.21%3.66%-23.86%-13.79%
Cost of Revenue
161.64177.74160.37131.43122.47168.58
Gross Profit
115.48114.76104.35104.49105.11130.3
Selling, General & Admin
60.5859.0653.5455.2251.1852.74
Operating Expenses
60.5859.0253.5955.2251.2152.74
Operating Income
54.9155.7450.7649.2753.8977.56
Interest Expense
-1.95-1.76-1.3-1.09-0.88-0.77
Interest & Investment Income
2.52.411.830.730.470.56
Earnings From Equity Investments
-0.271.728.724.682.720.64
Currency Exchange Gain (Loss)
0.540.180.31-0.520.20.44
Other Non Operating Income (Expenses)
3.760.281.660.050.040.07
EBT Excluding Unusual Items
59.4858.5661.9953.1456.4478.49
Gain (Loss) on Sale of Assets
------0.01
Asset Writedown
-----0.01
Other Unusual Items
-3.64-3.64---0.01
Pretax Income
55.8454.9261.9953.1456.4478.5
Income Tax Expense
11.110.8912.2510.8311.2915.7
Earnings From Continuing Operations
44.7444.0349.7442.3145.1562.8
Net Income
44.7444.0349.7442.3145.1562.8
Net Income to Common
44.7444.0349.7442.3145.1562.8
Net Income Growth
5.25%-11.49%17.57%-6.29%-28.10%14.24%
Shares Outstanding (Basic)
262626262626
Shares Outstanding (Diluted)
262626262626
Shares Change (YoY)
0.01%-0.02%-0.00%-0.02%-0.03%2.08%
EPS (Basic)
1.751.721.941.651.762.45
EPS (Diluted)
1.751.721.941.651.762.45
EPS Growth
5.85%-11.39%17.58%-6.25%-28.16%11.88%
Free Cash Flow
37.611.0427.8340.8866.62-40.89
Free Cash Flow Per Share
1.470.041.081.592.60-1.59
Dividend Per Share
1.5001.5001.6501.5001.6002.000
Dividend Growth
-9.09%-9.09%10.00%-6.25%-20.00%5.26%
Gross Margin
41.67%39.23%39.42%44.29%46.18%43.59%
Operating Margin
19.81%19.06%19.18%20.88%23.68%25.95%
Profit Margin
16.14%15.05%18.79%17.94%19.84%21.01%
Free Cash Flow Margin
13.57%0.35%10.51%17.33%29.27%-13.68%
EBITDA
64.0464.4558.9656.9162.0785.24
EBITDA Margin
23.11%22.04%22.27%24.12%27.27%28.52%
D&A For EBITDA
9.138.718.27.648.187.68
EBIT
54.9155.7450.7649.2753.8977.56
EBIT Margin
19.81%19.06%19.18%20.88%23.68%25.95%
Effective Tax Rate
19.88%19.83%19.76%20.38%20.00%20.00%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.